{"title":"苯巴比妥的药代动力学和最佳剂量。","authors":"Safiullah Shareef, Murtaza N Ali","doi":"10.15844/pedneurbriefs-32-7","DOIUrl":null,"url":null,"abstract":"<p><p>Researchers from the Baylor College of Medicine in Houston, TX, USA, conducted a <i>retrospective population pharmacokinetic</i> analysis of 355 patients ages less than 19 years of age in the inpatient setting who were initiated on intravenous or oral phenobarbital therapy and had one or more serum phenobarbital concentrations sampled.</p>","PeriodicalId":30710,"journal":{"name":"Pediatric Neurology Briefs","volume":"32 ","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2018-09-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.15844/pedneurbriefs-32-7","citationCount":"2","resultStr":"{\"title\":\"Pharmacokinetics and Optimal Dosing of Phenobarbital.\",\"authors\":\"Safiullah Shareef, Murtaza N Ali\",\"doi\":\"10.15844/pedneurbriefs-32-7\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Researchers from the Baylor College of Medicine in Houston, TX, USA, conducted a <i>retrospective population pharmacokinetic</i> analysis of 355 patients ages less than 19 years of age in the inpatient setting who were initiated on intravenous or oral phenobarbital therapy and had one or more serum phenobarbital concentrations sampled.</p>\",\"PeriodicalId\":30710,\"journal\":{\"name\":\"Pediatric Neurology Briefs\",\"volume\":\"32 \",\"pages\":\"7\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-09-05\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.15844/pedneurbriefs-32-7\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Pediatric Neurology Briefs\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15844/pedneurbriefs-32-7\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Pediatric Neurology Briefs","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15844/pedneurbriefs-32-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Pharmacokinetics and Optimal Dosing of Phenobarbital.
Researchers from the Baylor College of Medicine in Houston, TX, USA, conducted a retrospective population pharmacokinetic analysis of 355 patients ages less than 19 years of age in the inpatient setting who were initiated on intravenous or oral phenobarbital therapy and had one or more serum phenobarbital concentrations sampled.
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
